Ferring would like to use cookies to better understand your use of this website and improve your experience while navigating it. Please accept our use of cookies in accordance with our privacy policy. 

Accept / Decline


Ferring Canada Transfers the Divigel® Marketing Rights to Teva Canada Innovation

Effective February 14, 2014, Ferring Canada will transfer the Marketing Rights for Divigel® (DIN: 02377098) to Teva Canada Innovation. Teva Canada Innovation will now manage relationships with healthcare practitioners, community, chain and banner pharmacies, and payers in Canada as they relate to Divigel®.

See more Newsroom


Ferring Canada
200 Yorkland Boulevard, Suite 500
Toronto, Ontario, M2J 5C1 

Tel:  +1 416 490 0121 or +1 800 263 4057
Fax: 416 493 1692